Sequencing a single genome yields cause of inherited bone disorder

June 17, 2010, Duke University Medical Center

Combining new, whole-genome sequencing technology with classic genetic approaches to understanding inherited diseases, Duke University Medical Center geneticists and colleagues at Johns Hopkins have discovered two gene mutations that cause metachondromatosis, a rare, heritable disorder that leads to bony growths, typically on hands and feet.

They did it by sequencing the entire genome of just one individual.

Traditionally, rare inherited diseases (sometimes called "Mendelian" diseases, referring to those caused by mutations in a single gene and passed on through classic genetic patterns) have been studied using an approach called "linkage" in which a small number of markers are assessed for co-inheritance with the disease. The approach has been successful in many cases, but it can be very time-consuming and has been unsuccessful in as many as 1,500 studies where the presence of a gene inherited in Mendelian fashion is suspected, but has not been found, according to David Goldstein, PhD, director of the Center for Human Genome Variation at Duke.

Goldstein says a new strategy his team used to find mutations that cause metachondromatosis enables faster identification of Mendelian genes. "But perhaps more important, it may allow us to identify a lot of Mendelian genes that have been difficult to pin down with traditional analyses."

The opportunity to study genetic causes of metachondromatosis arose when Goldstein was lecturing at Johns Hopkins. Nara Sobreira, a graduate student in human genetics at Hopkins and a lead author of the study, mentioned to Goldstein that she was studying a small family that included six individuals across four generations affected with metachondromatosis.

The research team chose one member of the family and sequenced the entire genome of that person. Next, they used data from partial linkage data from other family members to identify areas in the genome where potentially causative mutations were most likely to be found. The analysis turned up six probable regions, implicating about one percent of the total genome. "This amount of genetic material would be very challenging to sequence using traditional strategies," said Goldstein.

The team used whole to zero in on a tiny string of 11 base pairs deleted from exon four of a gene called PTPN11. They found that all members of the family affected with metachondromatosis carried this mutation. The researchers confirmed PTPN11 alteration as the cause of the disease when they found a different mutation in the same gene in a second family with a history of the disease that also appeared in all of those affected with the disorder. Both mutations were predicted to lead to loss of function, or the inability of the body to make a protein necessary for normal development.

The researchers also sequenced exon 4 of PTPN11 - the location of the causal mutations - in 469 unrelated controls but did not find any mutations in the gene in that group.

Elizabeth Cirulli, a graduate student at Duke, a lead author and a member of Goldstein's team, says this is the first time that nonsense mutations in PTPN11 - errors that disable a protein -- have been described in human disease. "The next step would be to figure out how this mutation directly contributes to the development of metachondromatosis," she said.

Sobreira said that finding the gene that causes metachondromatosis may also reveal the of other diseases, like Maffucci syndrome and Ollier's disease, since individuals with those disorders share similar physical characteristics with those who have metachondromatosis.

Goldstein says the study adds to a small but growing list of examples where whole-genome sequencing approaches have successfully identified rare, high-penetrant risk factors for disease. Penetrance is a measure of how potent a mutation is in causing disease.

"The fact that linkage evidence was able to narrow our search for variants to just a fraction of what it might otherwise have been, cut our research time considerably," Goldstein says. He says that one interesting feature of this study is that the initial linkage evidence was only modest, approaching the sort of linkage evidence sometimes seen in large, multiple families for common diseases. "We are therefore hopeful that this sort of family-based sequencing might have utility in the study of genetic variants involved in more common diseases."

Explore further: Assay for genetic quirk can provide a wealth of information on patient disease status and prognosis

More information: Sobreira NLM, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, et al. (2010) Whole-Genome Sequencing of a Single Proband Together with Linkage Analysis Identifies a Mendelian Disease Gene. PLoS Genet 6(6): e1000991. doi:10.1371/journal.pgen.1000991

Related Stories

Assay for genetic quirk can provide a wealth of information on patient disease status and prognosis

March 16, 2018
Despite great advances in medicine, cancer remains a death sentence for many. "Patients are still dying from breast cancer relapse," says Jian Yuan Goh, of A*STAR's Genome Institute of Singapore. The researcher and his colleagues, ...

Genetic heart diseases cause fewer SIDS deaths than previously thought, study finds

March 12, 2018
Genetic mutations linked to heart disease have been considered a leading cause of sudden infant death syndrome, but a new study by Mayo Clinic, British and Danish researchers finds they are to blame for far fewer SIDS deaths ...

Influenza's wild origins in the animals around us

March 16, 2018
In the early 20th century, the leading cause of death was infectious disease. Epidemics erupted with little warning, seemingly out of the blue. When the "Great Influenza" struck in 1918, it killed thousands of people a week ...

Scientists find treasure trove of 110 genes linked to breast cancer

March 12, 2018
Scientists have linked 110 genes to an increased risk of breast cancer in the most comprehensive study ever to unpick the genetics of the disease.

Genomic analysis reveals why asthma inhalers fail minority children

March 15, 2018
The largest-ever whole-genome sequencing study of drug response in minority children has revealed new clues about why the front-line asthma drug albuterol does not work as well for African-American and Puerto Rican children ...

Researchers discover structure of protein associated with inflammation, Parkinson's

March 12, 2018
In a recent paper published in Nature Communications, Saint Louis University scientists report that they have determined the structure of a key protein that is involved in the body's inflammatory response. This finding opens ...

Recommended for you

New methods find undiagnosed genetic diseases in electronic health records

March 15, 2018
Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.

Hundreds of genes linked to intelligence in global study

March 14, 2018
More than 500 genes linked to intelligence have been identified in the largest study of its kind. Scientists compared variation in DNA in more than 240,000 people from around the world, to discover which genes are associated ...

Study finds that genes play a role in empathy

March 12, 2018
A new study published today suggests that how empathic we are is not just a result of our upbringing and experience but also partly a result of our genes.

Large-scale genetic study provides new insight into the causes of stroke

March 12, 2018
An international research consortium studying 520,000 individuals from around the world has identified 22 new genetic risk factors for stroke, thus tripling the number of gene regions known to affect stroke risk. The results ...

Study suggests some CpGs in the genome can be hemimethylated by design

March 9, 2018
A pair of researchers at Emory University has found that some CpGs in the genome can be hemimethylated by design, rather than by chance. In their paper published in the journal Science, Chenhuan Xu and Victor Corces describe ...

Intravenous arginine benefits children after acute metabolic strokes

March 9, 2018
Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid intravenous treatment with the amino acid arginine, experiencing no side effects from the treatment. The diseases were caused ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.